T cell factor 1: A master regulator of the T cell response in disease-Reference-Cited by-同舟云学术

T cell factor 1: A master regulator of the T cell response in disease

Published:2020-11-13 Issue:53 Volume:5 Page:
ISSN:2470-9468
Container-title:Science Immunology
language:en
Short-container-title:Sci. Immunol.

Author:

Escobar Giulia¹^ORCID,Mangani Davide¹^ORCID,Anderson Ana C.¹^ORCID

Affiliation:

1. Evergrande Center for Immunologic Diseases and Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women’s Hospital Mass General Brigham, Boston, MA 02115, USA.

Abstract

This review discusses TCF1, which plays context-dependent roles in T cell function during autoimmunity, cancer, and chronic infection.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine,Immunology

Reference121 articles.

1. Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box.

2. A critical role for TCF-1 in T-lineage specification and differentiation

3. An HMG-box-containing T-cell factor required for thymocyte differentiation

4. Critical involvement of Tcf-1 in expansion of thymocytes;Schilham M. W.;J. Immunol.,1998

5. Control of Lymphocyte Fate, Infection, and Tumor Immunity by TCF-1

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes;Molecular Cancer;2024-09-09

2. Co-stimulation of CD28/CD40 signaling molecule potentiates CAR-T cell efficacy and stemness;Molecular Therapy: Oncology;2024-09

3. Copy Number Profiling Implicates Thin High-Grade Squamous Intraepithelial Lesions as a True Precursor of Cervical Human Papillomavirus-Induced Squamous Cell Cancer;Laboratory Investigation;2024-09

4. New opportunities to overcome T cell dysfunction: the role of transcription factors and how to target them;Trends in Biochemical Sciences;2024-09

5. CD64⁺fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs efficacy against pancreatic cancer by reducing desmoplasia and enriching stem-like CD8⁺T cells;Gut;2024-08-26